| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine
|
Oxley, Kyp L.
|
|
|
70 |
11 |
p. 3093-3103
|
artikel
|
| 2 |
Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area
|
Stroh, Gregory R.
|
|
|
70 |
11 |
p. 3105-3111
|
artikel
|
| 3 |
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
|
Herting, Cameron J.
|
|
|
70 |
11 |
p. 3337-3348
|
artikel
|
| 4 |
Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
|
Dozin, Beatrice
|
|
|
70 |
11 |
p. 3349-3355
|
artikel
|
| 5 |
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab
|
Qi, Wei-Xiang
|
|
|
70 |
11 |
p. 3199-3206
|
artikel
|
| 6 |
Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen
|
Stringhini, Marco
|
|
|
70 |
11 |
p. 3183-3197
|
artikel
|
| 7 |
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
|
van Eck van der Sluijs, Jesper
|
|
|
70 |
11 |
p. 3167-3181
|
artikel
|
| 8 |
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
|
Verver, Danielle
|
|
|
70 |
11 |
p. 3123-3135
|
artikel
|
| 9 |
CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
|
Wu, Xuehui
|
|
|
70 |
11 |
p. 3235-3248
|
artikel
|
| 10 |
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis
|
He, Min-Ke
|
|
|
70 |
11 |
p. 3207-3216
|
artikel
|
| 11 |
Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens
|
Gao, Junxia
|
|
|
70 |
11 |
p. 3291-3302
|
artikel
|
| 12 |
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells
|
Van der Meer, J. M. R.
|
|
|
70 |
11 |
p. 3367
|
artikel
|
| 13 |
Correction to: Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer
|
Zadka, Łukasz
|
|
|
70 |
11 |
p. 3365
|
artikel
|
| 14 |
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
|
Fear, Vanessa S.
|
|
|
70 |
11 |
p. 3259
|
artikel
|
| 15 |
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
|
Arranz-Nicolás, Javier
|
|
|
70 |
11 |
p. 3277-3289
|
artikel
|
| 16 |
Distinct genomic features across cytolytic subgroups in skin melanoma
|
Roufas, Constantinos
|
|
|
70 |
11 |
p. 3137-3154
|
artikel
|
| 17 |
Enhancement of innate and adaptive anti-tumor immunity by serum obtained from vascular photodynamic therapy-cured BALB/c mouse
|
Zhang, Ying
|
|
|
70 |
11 |
p. 3217-3233
|
artikel
|
| 18 |
Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer
|
Seo, Won Ik
|
|
|
70 |
11 |
p. 3113-3122
|
artikel
|
| 19 |
Identification of mouse helper epitopes for WT1-specific CD4+ T cells
|
Nakajima, Hiroko
|
|
|
70 |
11 |
p. 3323-3335
|
artikel
|
| 20 |
Immune checkpoint inhibitors-induced nephropathy: a French national survey
|
Gérard, Alexandre O.
|
|
|
70 |
11 |
p. 3357-3364
|
artikel
|
| 21 |
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
|
Witt, Kristina
|
|
|
70 |
11 |
p. 3155-3166
|
artikel
|
| 22 |
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations
|
Uher, Ondrej
|
|
|
70 |
11 |
p. 3303-3312
|
artikel
|
| 23 |
RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation
|
Chen, Pingfeng
|
|
|
70 |
11 |
p. 3261-3275
|
artikel
|
| 24 |
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study
|
Stege, H. M.
|
|
|
70 |
11 |
p. 3313-3322
|
artikel
|
| 25 |
Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis
|
Suazo-Zepeda, E.
|
|
|
70 |
11 |
p. 3069-3080
|
artikel
|
| 26 |
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
|
Ishikawa, Takeshi
|
|
|
70 |
11 |
p. 3081-3091
|
artikel
|
| 27 |
TARP as antigen in cancer immunotherapy
|
Vanhooren, Jolien
|
|
|
70 |
11 |
p. 3061-3068
|
artikel
|
| 28 |
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
|
Fear, Vanessa S.
|
|
|
70 |
11 |
p. 3249-3258
|
artikel
|
Tijdschrift beschrijving